Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Processing

News in brief

CHO genome sequenced to boost bioproduction

Last updated on 02-Aug-2011 at 11:27 GMT

Researchers have sequenced a Chinese hamster ovary (CHO) cell line to support improvements to biopharm protein production.

Significant improvements to yields are unlikely but sequencing the genome for CHO-K1 still gives researchers “another tool in the bioprocessing toolbox”. In particular, cell line engineering could benefit from the information.

The CHO-K1 genomic sequence will facilitate the design of targeted genetic manipulations to aid in cell line engineering…and allow for more comprehensive deployment of 'omic tools for CHO-K1 and related cell lines”, said the researchers in a paper published in Nature Biotechnology .

China-based BGI and US-based GT Life Sciences collaborated on sequencing the genome.

Subscribe to our FREE newsletter

Get FREE access to authoritative breaking news, videos, podcasts, webinars and white papers. SUBSCRIBE

Key Industry Events


Access all events listing

Our events, Events from partners...